Home
HelpTest ID FPSAS Prostate Specific Antigen, Ultrasensitive
Method Name
Roche PSA Quantitative Electrochemiluminescent Immunoassay
Reporting Name
PSA, UltrasensitiveSpecimen Type
VariesSubmit only 1 of the following specimens:
Serum:
Draw blood in serum gel tubes(s). Spin down and send 1 mL of serum frozen in a plastic vial.
Plasma:
Draw blood in a plasma gel tube(s). Spin down and send 1 mL plasma frozen in a plastic vial.
Note: Plain red, green top (sodium or lithium heparin), lavender (EDTA) or pink (K2EDTA) are also acceptable.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Frozen (preferred) | 180 days |
| Refrigerated | 5 days |
Clinical Information
The Roche PSA method is approved for use as an aid in the detection of prostate cancer when used in conjunction with a digital rectal exam in men age 50 and older. The Roche PSA is also indicated for the serial measurement of PSA to aid in the prognosis and management of prostate cancer patients. Elevated PSA concentrations can only suggest the presence of prostate cancer until biopsy is performed. PSA concentrations can also be elevated in benign prostatic hyperplasia or inflammatory conditions of the prostate. PSA is generally not elevated in healthy men or men with nonprostatic carcinoma.
Reference Values
0.00 – 4.00 ng/mL
Cautions
Results obtained with different methods or kits cannot be used interchangeably.
Day(s) Performed
Sunday through Saturday
Report Available
1 dayPerforming Laboratory
ARUP LaboratoriesCPT Code Information
84153